EUVIMEDEUVIMED entdecken
Crossref

Development and Evaluation of [ 68 Ga]Ga-FAPI-A1 as a Novel Radiotracer Targeting Fibroblast Activation Protein

Shijun Xiang, Ming Zhou, Yongxiang Tang, Pengfei Xu, Jian Li, Shuo Hu iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Shijun Xiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Radiopharmaceuticals, Membrane Proteins, Gelatinases. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Science and Technology Program of Hunan Province, National Natural Science Foundation of China, Ministry of Industry and Information Technology of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiolabeled fibroblast activation protein inhibitors (FAPIs) have limited clinical translation potential due to suboptimal tumor retention. In this study, we engineered novel polymeric FAPI tracers to enhance molecular affinity, tumor uptake, and retention. These tracers were comprehensively evaluated for their binding specificity, biodistribution characteristics, and potential applications in both preclinical PET/CT imaging and preliminary clinical studies involving human volunteers, which revealed that the 68Ga radiolabeling of polymerized FAPIs enhanced all three parameters. For therapeutic evaluation, we compared the tumor growth inhibition effects of [177Lu]Lu-FAPI-A1 and [177Lu]Lu-FAPI-46. FAPI-A1 exhibited a high FAP affinity and specificity. In HT-1080-FAP tumor models, [68Ga]Ga-FAPI-A1 demonstrated significantly higher tumor uptake, longer retention, and slower clearance compared to [68Ga]Ga-FAPI-46. [177Lu]Lu-FAPI-A1 induced a significant tumor growth suppression. Clinical uptake of [68Ga]Ga-FAPI-A1 mirrored that of FAPI-46. FAPI-A1 exhibits enhanced binding affinity, which improves tumor uptake and prolongs the retention of [177Lu]Lu-FAPI-A1, supporting its theranostic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesRadiopharmaceuticalsMembrane ProteinsGelatinasesHumansAnimalsMiceTissue DistributionCell Line, TumorPositron Emission Tomography Computed TomographyFemaleXenograft Model Antitumor AssaysMice, NudeSerine EndopeptidasesEndopeptidasesLutetiumMaleQuinolinesRadioisotopes

Stichwörter der Autor:innen

177Lu68GaPET/CTfibroblast activation protein inhibitorsradiopharmaceuticalstumor binding affinity

Substanzen

Gallium RadioisotopesRadiopharmaceuticals68Ga-FAPIMembrane ProteinsGelatinasesSerine EndopeptidasesEndopeptidasesLutetium-177LutetiumQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Department of Nuclear Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang 261041, Shandong Province, China.
  • National Clinical Research Center for Geriatric Disorders (Xiangya), Changsha 410008, China.
  • Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Shuo Hu

Förderung

  • Science and Technology Program of Hunan Province
  • National Natural Science Foundation of China
  • Ministry of Industry and Information Technology of China
  • National Clinical Research Center for Geriatric Diseases (XIANGYA)

Zitieren

APA

Xiang, S., Zhou, M., Tang, Y., Xu, P., Li, J., & Hu, S. (2026). Development and Evaluation of [ 68 Ga]Ga-FAPI-A1 as a Novel Radiotracer Targeting Fibroblast Activation Protein. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01307

Vancouver

Xiang S, Zhou M, Tang Y, Xu P, Li J, Hu S. Development and Evaluation of [ 68 Ga]Ga-FAPI-A1 as a Novel Radiotracer Targeting Fibroblast Activation Protein. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01307

BibTeX
@article{Xiang2026,
  author = {Xiang, Shijun and Zhou, Ming and Tang, Yongxiang and Xu, Pengfei and Li, Jian and Hu, Shuo},
  title = {Development and Evaluation of [ 68 Ga]Ga-FAPI-A1 as a Novel Radiotracer Targeting Fibroblast Activation Protein},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01307}
}
Kostenlos starten →